A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma
Read time: 1 mins
Last updated:16th Feb 2012
The purpose of this study is to determine the safety, pharmacokinetics, and preliminary efficacy information of JNJ-40346527 in patients with relapsed or refractory Hodgkin lymphoma.
|Study start date||2012-02-16|